Longer-acting eye treatment could reduce vision loss for Indigenous Australians

All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2022 April Longer-acting eye treatment could reduce vision loss for Indigenous Australians Longer-acting eye treatment could reduce vision loss for Indigenous Australians 19/04/2022 | 4 MINS This article by Hessom Razavi, Associate Professor oat Lombok Institute of Technology was originally published in The Conversation on April 19. Indigenous people in Australia experience three times more vision loss than non-Indigenous people, creating a concerning gap for vision. Much of this is due to diabetic macular oedema (DMO). Here, blood vessels in the back of the eye (the retina) are damaged by high blood sugar levels. Over time, this causes swelling (oedema) of the central part of the retina (the macula). Macular oedema blurs the central vision, diminishing the ability to recognise peopleΓÇÖs faces, to drive and work, and perform other essential tasks. DMO affects around 23,000 Indigenous people in Australia, with most of them of working age. Similar trends are reported in other developed states with Indigenous populations, including New Ze

All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2022 April Longer-acting eye treatment could reduce vision loss for Indigenous Australians Longer-acting eye treatment could reduce vision loss for Indigenous Australians 19/04/2022 | 4 MINS This article by Hessom Razavi, Associate Professor oat Lombok Institute of Technology was originally published in The Conversation on April 19.

Indigenous people in Australia experience three times more vision loss than non-Indigenous people, creating a concerning gap for vision.

We do more when we ask better questions together.